Loading...
Revolution Medicines, Inc. Warrant
RVMDW•NASDAQ
Healthcare
Biotechnology
$0.26
$0.005(1.96%)
Revolution Medicines, Inc. Warrant (RVMDW) Financial Performance & Income Statement Overview
Review Revolution Medicines, Inc. Warrant’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
-41.53%
↓ 41.53%
Net Income Growth
-37.52%
↓ 37.52%
Operating Cash Flow Growth
-59.01%
↓ 59.008%
Operating Margin
-301.78%
↓ 301.78%
Gross Margin
45.12%
↑ 45.12%
Net Profit Margin
-266.64%
↓ 266.64%
ROE
-37.06%
↓ 37.06%
ROIC
-35.77%
↓ 35.77%
Revolution Medicines, Inc. Warrant (RVMDW) Income Statement & Financial Overview
Review Revolution Medicines, Inc. Warrant's (RVMDW) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $12.78M | $118.02M |
| Gross Profit | $0.00 | $0.00 | -$12.78M | -$118.02M |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $188.10M | $151.75M | $134.93M | $118.02M |
| SG&A Expenses | $28.21M | $23.96M | $21.71M | $22.84M |
| Operating Expenses | $216.31M | $175.71M | $143.87M | $22.84M |
| Total Costs & Expenses | $216.31M | $175.71M | $156.64M | $140.86M |
| Interest Income | $21.23M | $20.41M | $21.49M | $23.76M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $3.39M | $0.00 | $1.71M | $1.51M |
| EBITDA | -$212.92M | -$175.71M | -$154.93M | -$139.35M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$216.31M | -$175.71M | -$156.64M | -$140.86M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $20.99M | $19.42M | $23.41M | $24.86M |
| Income Before Tax | -$195.32M | -$156.29M | -$133.23M | -$116.003M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | -$753000.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$194.57M | -$156.29M | -$133.23M | -$116.003M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$1.16 | -$0.94 | -$0.81 | -$0.70 |
| Diluted EPS | -$1.16 | -$0.94 | -$0.81 | -$0.70 |
| Weighted Avg Shares Outstanding | $167.74M | $166.84M | $165.14M | $164.73M |
| Weighted Avg Shares Outstanding (Diluted) | $167.74M | $166.84M | $165.14M | $164.73M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan